Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer

Prospective Randomized Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer

To assess the improvement in sexual function and self-perceived quality of life using PROMs (Patient-Reported Outcomes) in patients treated for cervical cancer who undergo a multimodal intervention in the sexual sphere and lifestyle compared to those who undergo care within routine clinical practice.

Prospective, randomized 2:1 study in favor of the intervention group, multicenter, superiority, to be performed in patients treated for cervical cancer divided into 2 study groups: 1) intervention group that will undergo a multimodal intervention in the sexual sphere and lifestyle; and 2) control group according to routine clinical practice.

Inclusion Criteria:

• Women of legal age.
• Patients with primary cervical cancer stage FIGO I-III (initial or locally advanced) of squamous histology, adenocarcinoma or adenosquamous.
• Patients treated for cancer with surgery and/or radiotherapy ± systemic treatment in the Gynaecological Oncology Units of hospitals in Spain.
• Complete response after oncospecific treatment was obtained.
• Signature of the informed consent (IC) by the patient or responsible family member.

Exclusion Criteria:

• Patients under 18 years of age.
• Pregnancy or breastfeeding.
• Partial response after completion of oncospecific treatment.
• Patients with premalignant pathology.
• Diagnosis of a tumor of non-cervical origin or atypical histologies.
• Impossibility of completing the questionnaires included in the protocol autonomously.
• Contraindications to the use of vaginal estrogens.
• Patients undergoing fertility-sparing treatment (trachelectomy or conization).
• Patients undergoing palliative treatment.